Author : Storozhenko S.A.
The role of T790M mutation in first- and second-line therapy of patients with EGFR-positive non-small cell lung cancerAuthors: Storozhenko S.A. Shparyk Ya.V. Т. 13, № 1 (49)
|
|
|
|
|
Author : Storozhenko S.A.The role of T790M mutation in first- and second-line therapy of patients with EGFR-positive non-small cell lung cancerAuthors: Storozhenko S.A. Shparyk Ya.V. Т. 13, № 1 (49) |
|